The Digital Way to Intercept Psoriatic Arthritis

Psoriasis (PsO) and Psoriatic Arthritis (PsA) are chronic, immune-mediated diseases that share common etiopathogenetic pathways. Up to 30% of PsO patient may later develop PsA. In nearly 75% of cases, skin psoriatic lesions precede arthritic symptoms, typically 10 years prior to the onset of joint s...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ivan Giovannini, Philipp Bosch, Christian Dejaco, Gabriele De Marco, Dennis McGonagle, Luca Quartuccio, Salvatore De Vita, Enzo Errichetti, Alen Zabotti
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	Psoriatic Arthritis (PsA) psoriasis technology prevention interception early diagnosis Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/98e860cef54348c68ea67a26706b5e81
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:98e860cef54348c68ea67a26706b5e81
record_format	dspace
spelling	oai:doaj.org-article:98e860cef54348c68ea67a26706b5e812021-11-30T12:45:23ZThe Digital Way to Intercept Psoriatic Arthritis2296-858X10.3389/fmed.2021.792972https://doaj.org/article/98e860cef54348c68ea67a26706b5e812021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmed.2021.792972/fullhttps://doaj.org/toc/2296-858XPsoriasis (PsO) and Psoriatic Arthritis (PsA) are chronic, immune-mediated diseases that share common etiopathogenetic pathways. Up to 30% of PsO patient may later develop PsA. In nearly 75% of cases, skin psoriatic lesions precede arthritic symptoms, typically 10 years prior to the onset of joint symptoms, while PsO diagnosis occurring after the onset of arthritis is described only in 15% of cases. Therefore, skin involvement offers to the rheumatologist a unique opportunity to study PsA in a very early phase, having a cohort of psoriatic “risk patients” that may develop the disease and may benefit from preventive treatment. Progression from PsO to PsA is often characterized by non-specific musculoskeletal symptoms, subclinical synovio-entheseal inflammation, and occasionally asymptomatic digital swelling such as painless toe dactylitis, that frequently go unnoticed, leading to diagnostic delay. The early diagnosis of PsA is crucial for initiating a treatment prior the development of significant and permanent joint damage. With the ongoing development of pharmacological treatments, early interception of PsA has become a priority, but many obstacles have been reported in daily routine. The introduction of digital technology in rheumatology may fill the gap in the physician-patient relationship, allowing more targeted monitoring of PsO patients. Digital technology includes telemedicine, virtual visits, electronic health record, wearable technology, mobile health, artificial intelligence, and machine learning. Overall, this digital revolution could lead to earlier PsA diagnosis, improved follow-up and disease control as well as maximizing the referral capacity of rheumatic centers.Ivan GiovanniniPhilipp BoschChristian DejacoGabriele De MarcoDennis McGonagleLuca QuartuccioSalvatore De VitaEnzo ErrichettiAlen ZabottiFrontiers Media S.A.articlePsoriatic Arthritis (PsA)psoriasistechnologypreventioninterceptionearly diagnosisMedicine (General)R5-920ENFrontiers in Medicine, Vol 8 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Psoriatic Arthritis (PsA) psoriasis technology prevention interception early diagnosis Medicine (General) R5-920
spellingShingle	Psoriatic Arthritis (PsA) psoriasis technology prevention interception early diagnosis Medicine (General) R5-920 Ivan Giovannini Philipp Bosch Christian Dejaco Gabriele De Marco Dennis McGonagle Luca Quartuccio Salvatore De Vita Enzo Errichetti Alen Zabotti The Digital Way to Intercept Psoriatic Arthritis
description	Psoriasis (PsO) and Psoriatic Arthritis (PsA) are chronic, immune-mediated diseases that share common etiopathogenetic pathways. Up to 30% of PsO patient may later develop PsA. In nearly 75% of cases, skin psoriatic lesions precede arthritic symptoms, typically 10 years prior to the onset of joint symptoms, while PsO diagnosis occurring after the onset of arthritis is described only in 15% of cases. Therefore, skin involvement offers to the rheumatologist a unique opportunity to study PsA in a very early phase, having a cohort of psoriatic “risk patients” that may develop the disease and may benefit from preventive treatment. Progression from PsO to PsA is often characterized by non-specific musculoskeletal symptoms, subclinical synovio-entheseal inflammation, and occasionally asymptomatic digital swelling such as painless toe dactylitis, that frequently go unnoticed, leading to diagnostic delay. The early diagnosis of PsA is crucial for initiating a treatment prior the development of significant and permanent joint damage. With the ongoing development of pharmacological treatments, early interception of PsA has become a priority, but many obstacles have been reported in daily routine. The introduction of digital technology in rheumatology may fill the gap in the physician-patient relationship, allowing more targeted monitoring of PsO patients. Digital technology includes telemedicine, virtual visits, electronic health record, wearable technology, mobile health, artificial intelligence, and machine learning. Overall, this digital revolution could lead to earlier PsA diagnosis, improved follow-up and disease control as well as maximizing the referral capacity of rheumatic centers.
format	article
author	Ivan Giovannini Philipp Bosch Christian Dejaco Gabriele De Marco Dennis McGonagle Luca Quartuccio Salvatore De Vita Enzo Errichetti Alen Zabotti
author_facet	Ivan Giovannini Philipp Bosch Christian Dejaco Gabriele De Marco Dennis McGonagle Luca Quartuccio Salvatore De Vita Enzo Errichetti Alen Zabotti
author_sort	Ivan Giovannini
title	The Digital Way to Intercept Psoriatic Arthritis
title_short	The Digital Way to Intercept Psoriatic Arthritis
title_full	The Digital Way to Intercept Psoriatic Arthritis
title_fullStr	The Digital Way to Intercept Psoriatic Arthritis
title_full_unstemmed	The Digital Way to Intercept Psoriatic Arthritis
title_sort	digital way to intercept psoriatic arthritis
publisher	Frontiers Media S.A.
publishDate	2021
url	https://doaj.org/article/98e860cef54348c68ea67a26706b5e81
work_keys_str_mv	AT ivangiovannini thedigitalwaytointerceptpsoriaticarthritis AT philippbosch thedigitalwaytointerceptpsoriaticarthritis AT christiandejaco thedigitalwaytointerceptpsoriaticarthritis AT gabrieledemarco thedigitalwaytointerceptpsoriaticarthritis AT dennismcgonagle thedigitalwaytointerceptpsoriaticarthritis AT lucaquartuccio thedigitalwaytointerceptpsoriaticarthritis AT salvatoredevita thedigitalwaytointerceptpsoriaticarthritis AT enzoerrichetti thedigitalwaytointerceptpsoriaticarthritis AT alenzabotti thedigitalwaytointerceptpsoriaticarthritis AT ivangiovannini digitalwaytointerceptpsoriaticarthritis AT philippbosch digitalwaytointerceptpsoriaticarthritis AT christiandejaco digitalwaytointerceptpsoriaticarthritis AT gabrieledemarco digitalwaytointerceptpsoriaticarthritis AT dennismcgonagle digitalwaytointerceptpsoriaticarthritis AT lucaquartuccio digitalwaytointerceptpsoriaticarthritis AT salvatoredevita digitalwaytointerceptpsoriaticarthritis AT enzoerrichetti digitalwaytointerceptpsoriaticarthritis AT alenzabotti digitalwaytointerceptpsoriaticarthritis
_version_	1718406578661490688

The Digital Way to Intercept Psoriatic Arthritis

Ejemplares similares